From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
United Kingdom
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2024
- 80 Pages
Vietnam
From €1346EUR$1,500USD£1,158GBP
- Report
- February 2024
- 117 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Report
- April 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,047GBP
Pyrazinamide is a drug used to treat respiratory diseases, such as tuberculosis. It is a prodrug, meaning it is converted to an active form in the body. It is usually used in combination with other drugs, such as isoniazid and rifampicin, to treat tuberculosis. Pyrazinamide is also used to treat other respiratory diseases, such as Mycobacterium avium complex (MAC) and Mycobacterium kansasii.
Pyrazinamide is available in both oral and injectable forms. It is generally well tolerated, with few side effects. However, it can cause liver damage in some patients, so it is important to monitor liver function when taking this drug.
The pyrazinamide market is a growing one, with many companies offering products. Some of these companies include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more